Charles River Laboratories International Inc (CRL)
195.77
+1.58
(+0.81%)
USD |
NYSE |
Nov 22, 16:00
195.80
+0.03
(+0.02%)
After-Hours: 20:00
Charles River Laboratories International Gross Profit Margin (Quarterly): 34.56% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 34.56% |
| June 30, 2024 | 34.47% |
| March 31, 2024 | 34.09% |
| December 31, 2023 | 35.92% |
| September 30, 2023 | 35.25% |
| June 30, 2023 | 37.64% |
| March 31, 2023 | 36.69% |
| December 31, 2022 | 36.27% |
| September 30, 2022 | 37.43% |
| June 30, 2022 | 36.66% |
| March 31, 2022 | 36.85% |
| December 31, 2021 | 38.35% |
| September 30, 2021 | 37.64% |
| June 30, 2021 | 37.40% |
| March 31, 2021 | 37.39% |
| December 31, 2020 | 37.92% |
| September 30, 2020 | 38.92% |
| June 30, 2020 | 34.02% |
| March 31, 2020 | 35.65% |
| December 31, 2019 | 37.95% |
| September 30, 2019 | 36.85% |
| June 30, 2019 | 36.21% |
| March 31, 2019 | 35.03% |
| December 31, 2018 | 37.64% |
| September 30, 2018 | 36.94% |
| Date | Value |
|---|---|
| June 30, 2018 | 36.90% |
| March 31, 2018 | 36.74% |
| December 31, 2017 | 34.98% |
| September 30, 2017 | 38.09% |
| June 30, 2017 | 39.50% |
| March 31, 2017 | 38.44% |
| December 31, 2016 | 37.96% |
| September 30, 2016 | 36.71% |
| June 30, 2016 | 39.11% |
| March 31, 2016 | 39.67% |
| December 31, 2015 | 39.73% |
| September 30, 2015 | 39.51% |
| June 30, 2015 | 39.10% |
| March 31, 2015 | 37.35% |
| December 31, 2014 | 36.40% |
| September 30, 2014 | 36.10% |
| June 30, 2014 | 36.82% |
| March 31, 2014 | 36.35% |
| December 31, 2013 | 30.49% |
| September 30, 2013 | 34.21% |
| June 30, 2013 | 35.01% |
| March 31, 2013 | 35.78% |
| December 31, 2012 | 32.49% |
| September 30, 2012 | 33.46% |
| June 30, 2012 | 36.38% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
34.02%
Minimum
Jun 2020
38.92%
Maximum
Sep 2020
36.55%
Average
36.77%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 68.83% |
| CVS Health Corp | 13.16% |
| Arbutus Biopharma Corp | -- |
| FibroBiologics Inc | -- |
| Biomarin Pharmaceutical Inc | 74.73% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 11.28% |
| Return on Assets | 5.18% |
| Return on Invested Capital | 6.69% |
| Profit Margin (Quarterly) | 6.80% |
| Operating Margin (Quarterly) | 11.63% |
| Return on Net Operating Assets | 5.81% |